6^th International Conference on Hematology October 03-05, 2016 Orlando, Florida, USA

Knox Van Dyke has completed his PhD in Biochemistry in the Nobel Prize Department of Dr. Edward A Doisy at Saint Louis University in 1966. He began to study about malaria at West Virginia University Medical School and developed the first high throughput screening system for anti-malarial drugs identifying mefloquine and halofantrine which were commercially developed. He and Associate Professor Zuguang Ye recognized bisbenzylisoquinolines synergize with chloroquine causing resistance reversal to chloroquine as demonstrated in Aotus monkeys creating a malarial cure. He has edited and published 7 books for CRC Press, Boca Raton Florida and has written over 300 manuscripts.

Hematology

Robert Michael Davidson has completed his PhD in Pharmaceutical Chemistry from UCSF, NSF Postdoctoral Fellowship at the National Bureau of Standards, Center for Analytical Chemistry, MD degree at St Louis University School of Medicine, Nuclear Medicine Residency at Baylor College of Medicine, Houston, Texas and Internal Medicine Residency in Phoenix, Arizona. He was an Associate Medical Director for DuPont Pharma’s Radiopharmaceutical Division 1990-1992. He has published more than 30 papers in peer-reviewed journals. He is a Fellow of the American Institute of Stress (From 2012 to until now) and practicing complementary/alternative/integrative Internal Medicine in Gladewater, Texas, USA.

Physician

Dianzheng Zhang has completed his PhD from University of Arizona and Postdoctoral studies from Baylor College of Medicine. He assumed an Assistant Professor position at PCOM in 2006 and promoted to an Associate Professor in 2011. He has published more than 40 papers in reputed journals and has served as a chairman for multiple international conferences.

Hematology

Enzi Jiang received her MD from Norman Bethune College of Medicine, Jilin University, formerly Norman Bethune University of Medical Science, Changchun, China in 1987. She completed her PhD from Harbin Medical University in 1999 and Postdoctoral research from University of Texas Southwestern Medical Center at Dallas in 2007. She is working as a Senior Scientist at Division of Hematology and Oncology, Children’s Hospital Los Angeles University of Southern California Keck School of Medicine, Los Angeles, USA. She has published more than 15 papers in reputed journals related to mesenchymal stem cells and leukemia and contributed to a book chapter (Chapter 4: Molecular Pathogenesis of ALL, Contemporary Management of Acute Lymphoblastic Leukemia, In Press 2014). She has been serving as an Editorial Board Member for the Journal of Blood Disorders and Transfusion since February, 2013. Her research interests include overcoming drug resistance in ALL and related mechanisms.

Hematology and Oncology, mouse models of pre-B acute lymphoblastic leukemia, novel anticancer therapy

C Cameron Yin has received her MD from Beijing Medical University and her PhD from the University of Wisconsin-Madison. She is currently an Associate Professor in the Department of Hematopathology at the University of Texas MD Anderson Cancer Center. In addition to clinical responsibilities on the Leukemia, Lymphoma and Molecular Diagnostic services, she has been actively participating in multiple research projects in the molecular genetic abnormalities in leukemia and lymphoma which has led to over 100 research papers and over 20 book chapters.

Hematology